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Abstract 
Background: We aimed to test the validation of the European organization for research and treatment of cancer 
(EORTC) quality of life questionnaires for head and neck module (QLQ-H&N35) in a tertiary care center. 
Methods: Forty patients with head and neck malignancy completed the QLQ-H&N35 while undergoing their 
treatment. Questionnaires given to them were translated into their regional language Kannada. Evaluation of 
the responsiveness, reliability, and validity of the questionnaire was undertaken. 
Results: The data assessed the reliability of the scales and not validity. The questionnaire was receptive to changes 
over time; however, the applicability of the European questionnaire in Indian clinical set up was debatable. 
Conclusions: Our data suggests that the EORTC QLO-H&N35 is reliable and responsive when applied to 
patients with head and neck cancer in India. Hence, it may be used as a platform to test validity at a 
multicentric level. 
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Introduction 
Head and neck cancers amounts to 30% of all cancers 
in men and 13% in women in developing countries like 
India as compared to the west, where it accounts for 
only 5% of all cancers (1). As head and neck cancer is 
widely prevalent in Indian population, therefore it 
becomes important to measure the outcomes it has in 
terms of survival after appropriate treatment, and its 
impact on an individual's quality of life (QOL). To 
measure this impact, European Organization for 
Research and Treatment of Cancer Quality of Life 
Questionnaire (EORTC QLQ) was published after 
analyzing all the psychometric qualities for the very 
first time in 1992 (2). The first version of the EORTC 
QLQ module for patients with head and neck cancer 
(EORTC QLQ-H&N37) was published in 1994 (3), 
revised and validated in 1999 (4) as EORTC QLQ-
H&N35, which is used as a specific module for head 
and neck cancer. These questionnaires developed for 
the European countries, are culturally very different 
when used in our country. In India, the populations 
suffering from head and neck cancers are from low 
socioeconomic group; hence it hinders the usage and 
application of these questionnaires in our country. 
Specific module assesses the problems unique to head 
and neck cancer, such the approaches used in EORTC 
questionnaire which are used worldwide. The present 
study was a pilot study done to check the reliability as 
well as validity of EORTC QLQ-HN35 (head and 
neck-specific questionnaire). 
 
Materials and Methods 
This prospective longitudinal study was done in Father 
Muller Medical College, Mangalore, India, after 
obtaining clearance from the institutional ethics 
committee. 40 patients suffering from head and neck 
cancer visiting the outpatient departments of oncology 
(radiation, medical, and surgical) who were diagnosed 
with head and neck cancer of any subsite or stage with 
a definitive treatment plan formulated with a curative 
intent of any modality, willing to participate in the 
study were included. 
The patients not willing to participate in the study, 
those in between the treatment course, treatment 
defaulters, those with disease recurrences or relapses, 
patients receiving neoadjuvant treatment, and those not 
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available for long-term follow up were excluded from 
the study. 
All of the patients were investigated and staged, 
and appropriate treatment plan was formulated for 
them. These patients were given EORTC QLQ-HN35 
questionnaire, and asked to fill. The questionnaire was 
translated into Kannada as majority of the patients 
could read and comprehend it. The same group of 
patients were followed up posttreatment, and asked to 
fill the same set of questionnaires. A total of  
80 questionnaires were filled and analyzed. The 
questionnaires were rechecked and values were added 
wherever they were missing. The relevant clinical 
details including age, gender, level of education, site 
and stage of the tumor, and the treatment details were 
recorded from the hospital case files.  
 
Results 
Forty patients completed the questionnaire prior to 
commencement of treatment, and once after 
completion of treatment, giving a total of 80 completed 
questionnaires. All the patients filled this questionnaire 
in the translated version. Except for few, most of the 
questions were answered without assistance, brief 
explanation for the purpose of this study was provided 
for few. 
There were 38 men and 2 women patients. All of 
them were literate, and could understand the 
questionnaires well. Sites of primary tumor are 
described in table 1. Out of theses, 32 were referred for 
surgery, and 8 for concurrent chemoradiotherapy.  
Reliability was measured using Cronbach's alpha 
coefficient (Table 2). Most of the scales in both the 
questionnaires demonstrated a coefficient of > 0.70 
which was considered high. 
In EORTC QLQ-H&N35, global and pain scale 
showed a lower coefficient in both pretreatment 
(0.244/-0.059) and posttreatment (0.105/0.098), 
whereas swallowing scale showed lower coefficient in 
posttreatment scale (0.549) compared to pretreatment 
(0.726), and senses problem scale in pretreatment  
(-0.118) showed a lower coefficient compared to 
posttreatment (0.943). Other values in both 
questionnaires in all other domains demonstrated a 
high coefficient value (> 0.70). Hence, satisfactory 
results were achieved.   
 
Table 1. Site distribution of cases 
Site Subsite Frequency 
Oral cavity Lip 2 23 
Buccal mucosa 7 
GB sulcus 3 
Tongue 6 
FOM 1 
RMT 3 
Alveolus 1 
Oropharynx  1 
Larynx  5 
Hypopharynx 9 
Nose and paranasal sinuses (PNS) 2 
Total  40 
 
Considering clinical validity, with the respect to 
pretreatment and posttreatment values, the 
questionnaire showed statistically significant difference 
in all domains as all the p values are less than 0.001 
(Table 3). 
 
Discussion 
Head and neck cancer is quite prevalent in this part of 
the continent, and various studies have been published 
from different tertiary care centers, a lot has been 
discussed about its pathophysiology and control. In 
past few years, equal importance has been given to 
facial aesthetics, organ preservation, and QOL which 
formed an integral part of disease management. Oral 
cavity is the commonest subsite as seen in our study as 
well. Disease specific management of head and neck 
tumors can lead to structural defects and functional 
disability which affects the overall well-being, self-
esteem, and social integration and self-confidence of 
the patient. Treatment of head and neck tumors can be 
mutilating, thereby affecting the QOL. These 
questionnaires provide an opportunity to have insight 
about the mental and social impact the disease has on 
an individual which was noticed by Chaukar et al, (5). 
 
Table 2. Cronbach's alpha coefficient for different aspects of EORTC QLQ-H&N35 
Aspect Item Pretreatment Posttreatment 
Symptom scale    
Pain  31-34 0.105 0.098 
Swallowing problems 35-38 0.726 0.549 
Functional scale    
Trouble with social eating 49-52 0.861 0.919 
Less sexuality 59-60 1.000 1.000 
Speech problems 53-54 0.946 0.976 
Trouble with social contact 55-58 0.978 0.993 
Senses problems 43-44 -0.118 0.943 
Global scale 61-65 0.244 -0.059 
EORTC QLQ-H&N35: European Organization for Research and Treatment of Cancer Quality of 
Life Questionnaire-Head and Neck-35 
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Table 3. Test for validity between pretreatment and posttreatment scores in EORTC QLQ-H&N35 
Aspect Pretreatment Posttreatment P-value 
 Mean SD Mean SD  
Global 6.65 0.949 8.57 0.594 < 0.001 
Social eating 10.43 2.952 13.25 2.753 < 0.001 
Less sexuality 4.30 1.786 6.55 1.568 < 0.001 
Speech problems 5.05 1.894 6.60 1.464 < 0.001 
Social contact 9.57 3.587 12.65 3.438 < 0.001 
Pain 7.40 1.985 7.98 2.069 0.006 
Swallowing problems 9.63 2.789 10.83 2.194 0.001 
Senses problem 2.23 0.660 5.93 2.005 < 0.001 
EORTC QLQ-H&N35: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-
Head and Neck-35; SD: Standard deviation 
 
We, in our study, found similar usefulness of the 
questionnaire therefore, QOL is an important end-point 
in evaluating treatment outcomes, and mental and 
social well-being of patients with head and neck 
cancer. Various QLQ scales are available which can be 
used, but we chose a disease specific scale to enhance 
the outcome as mentioned by Tamburini (6).  
The QLQ-H&N35 has 35 questions, and is a head 
and neck specific questionnaire. The questions are 
broadly grouped as global, functional, and symptoms 
which are well balanced. In the translated 
questionnaire, all the items showed acceptable 
reliability, except for cognitive and pain items along 
with global and senses items. There was no statistically 
significant difference in interpretation between the 
scales as similar items were showing poor reliability 
with no association with other items. Most of the items 
showed high pretreatment reliability, and prospectively 
the scores improved in most of the cases; similar 
findings were reported by Melo Filho et al. (7) and 
Braam et al. (8) with slight contradiction with Bansal et 
al. (9) where they demonstrated positive correlation 
with worsening functions and increasing symptoms.  
This study was not done to assess the QOL based 
on the disease stage; but, when observed closely, the 
early stage tumors showed better QOL than those with 
advanced stage. However, there were too many 
confounding factors to comment upon the stage 
specific QOL which we thought was a shortcoming in 
this study, maybe a large volume stage specific QOL 
study can be done to address this.  
With respect to validity of the questionnaire, it can 
be stated that this questionnaire was not valid, but was 
reliable; this is because the sample size taken for this 
study was inadequate according to Kaiser-Meyer-Olkin 
measures of sample of adequacy (10). 
Certain questions were not very appropriate for 
Indian population, and many of our participants could 
not comprehend the questions related to sexual activity, 
as it either made them uncomfortable to answer; or the 
shear burden of the disease in terms of financial burden 
and loss of productivity made it impractical for them to 
associate their QOL with sexual life hence, we did not 
find it appropriate in our setting. Chaukar et al. in their 
study found similar responses, too (5). 
Vital property of QOL tools in a study is it’s 
responsiveness to changes to health status of the 
patient. In this study, there was a statistically 
significant difference in all the different domains as 
expected. Patients had a significant poor score in most 
of the scales in posttreatment compared to patients 
prior to treatment. However, based on the above 
results, it can be concluded that the new scale does not 
replace the older one. 
This study can be seen as a pilot study, and the 
positive data can be used to conduct a multicentric 
study across the state with a bigger sample size for 
better randomization. Therefore, this study can serve as 
a template to effectively test the validity of EORTC 
QLQ-H&N35 questionnaire. 
 
Conclusion 
EORTC QLQ-H&N35 questionnaire helps the clinician 
to gather disease specific QOL data which otherwise is 
often missed. This QOL questionnaire is highly 
reliable; however; validity warrants a much bigger 
study. The items included are all relevant except for 
few which may vary based on cultural differences. 
Core questionnaires may be combined with site 
specific questionnaires for better QOL outcome. This 
study can act as a template for testing effective validity 
in future. 
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